We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Traditional Chinese Medicinal Plant Extract Protects against PD

By LabMedica International staff writers
Posted on 22 Nov 2017
Print article
Image: Glycyrrhiza uralensis (Chinese licorice) is the source of the neuroprotective compound liquiritigenin (Photo courtesy of Wikimedia Commons).
Image: Glycyrrhiza uralensis (Chinese licorice) is the source of the neuroprotective compound liquiritigenin (Photo courtesy of Wikimedia Commons).
A team of Korean neurodegenerative disease researchers has identified a naturally occurring drug that prevents the death of dopamine-producing neurons that characterizes Parkinson's disease.

Parkinson's disease is a degenerative brain disorder caused by the death of dopaminergic neurons in the middle cerebral brain. It is a disease with a higher incidence in the elderly population, exhibiting symptoms such as tremors, stiffness, reduced motor capability, and postural instability.

RNF146 (RING finger protein 146) is an E3 ubiquitin ligase enzyme that specifically recognizes and polyubiquitinates poly (ADP-ribose) (PAR)-conjugated substrates for proteasomal degradation. RNF146 has been shown to be neuroprotective against PAR polymerase-1 (PARP1)-induced cell death during stroke.

To discover the mechanism that underlies the neuroprotective effect of RNF146, a team of Korean investigators used a high-throughput screen based on a luciferase construct harboring the RNF146 promoter to evaluate compounds in the natural materials library of the Natural Medicine Bank of the Korea Foundation.

The investigators reported in the October 11, 2017, online edition of the journal Oncotarget that they had identified the licorice extract liquiritigenin as a potent RNF146 inducer. RNF146 expression and the RNF146 inducer liquiritigenin could prevent cell death elicited by Parkinson’s disease-associated and PARP1-activating stimuli.

The investigators further reported that RNF146 expression by liquiritigenin was mediated by estrogen receptor activation and contributed to cytoprotective effect of liquiritigenin. In addition, RNF146 expression by liquiritigenin in mouse brains provided dopaminergic neuroprotection in a 6-hydroxydopamine Parkinson's disease mouse model.

Contributing author Dr. Yun-Il Lee, a senior researcher at Daegu Gyeongbuk Institute of Science and Technology, said, "Neuronal death is involved in a variety of signaling systems in vivo. Therefore, it is essential to identify a new mechanism that is able to control the system comprehensively and we have found additional possibilities in licorice extract. I would like to contribute to the treatment of degenerative brain diseases such as Parkinson's disease by conducting advanced researches, comprehensive research and clinical studies."

Related Links:
Daegu Gyeongbuk Institute of Science and Technology

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.